Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

623
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
623
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

472
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
472
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

681
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
681
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

679
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
679
Survival Tree01:19

Survival Tree

457
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
457
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

905
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
905

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of receptor-interacting protein kinase 3 inhibitor for atherosclerosis.

Journal of receptor and signal transduction research·2026
Same author

Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.

The journal of allergy and clinical immunology. In practice·2026
Same author

NeuroBACE-ML: A reliability-aware screening framework for high-throughput prioritization of potent BACE1 inhibitors.

Journal of molecular graphics & modelling·2026
Same author

Isolation, structural elucidation and <i>in-silico</i> screening of bioactive phytocompounds from <i>Averrhoa carambola</i> L. (Star Fruit) leaves as potential anti-inflammatory prophylaxis.

Natural product research·2026
Same author

Enhancing survival risk prediction through imputation and feature selection in high-dimensional protein biomarker data.

Scientific reports·2026
Same author

Quantifying Eligibility Pattern Shifts: a Data-Driven Paradigm for Early Risk Detection in Clinical Trials.

Therapeutic innovation & regulatory science·2026

Related Experiment Video

Updated: Mar 11, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Survival Proximity Score Matching: A Method for Censored Data Imputation in Multi-State Frailty Models.

Atanu Bhattacharjee, Gajendra K Vishwakarma, Bhrigu Kumar Rajbongshi

    IEEE Transactions on Computational Biology and Bioinformatics
    |March 9, 2026
    PubMed
    Summary

    This study improves survival analysis by using Multistate Models (MSMs) with frailty to accurately handle censored data and participant dropouts, reducing bias in treatment effect estimates.

    More Related Videos

    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    11.0K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.7K

    Related Experiment Videos

    Last Updated: Mar 11, 2026

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
    06:55

    Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

    Published on: January 8, 2020

    15.4K
    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    11.0K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.7K

    Area of Science:

    • Biostatistics
    • Survival Analysis
    • Epidemiology

    Background:

    • Censoring in survival analysis, often due to loss to follow-up, can bias treatment effect estimates.
    • Traditional Cox models have limitations in handling both censoring and complex multistate dynamics, especially with unobserved heterogeneity.
    • Multistate Models (MSMs) provide a flexible framework for time-to-event data with multiple event types and dependencies.

    Purpose of the Study:

    • To address censoring in survival analysis using an MSM framework.
    • To incorporate frailty adjustments for improved accuracy in modeling transitions.
    • To reduce bias in treatment effect estimates caused by censored observations.

    Main Methods:

    • Utilized Multistate Models (MSMs) to capture complex event transitions over time.
    • Implemented survival proximity score matching to handle censored data within the MSM.
    • Incorporated transition-specific frailty to account for unobserved individual variability.

    Main Results:

    • Observed increasing frailty variance across different transitions in the model.
    • Demonstrated significant variation in survival probabilities across different frailty levels.
    • Confirmed the value of frailty-adjusted MSMs for more accurate survival analysis.

    Conclusions:

    • Frailty-adjusted Multistate Models offer a robust approach to handling censoring and unobserved heterogeneity.
    • This method enhances the accuracy of time-to-event comparisons and treatment effect estimation.
    • The findings underscore the importance of accounting for individual variability in complex survival data analysis.